Posted by Michael Wonder on 21 Jul 2026
EMA accepts submission to update Bexsero label for 1 dose meningitis B booster in 10+ year olds
20 July 2026 - GSK today announced the EMA has accepted a submission to update the label for Bexsero to include a single dose booster for individuals aged 10 years and older who were previously vaccinated with Bexsero.
If a one-dose booster is approved, those vaccinated with Bexsero in childhood could receive a single Bexsero dose at age 10 years or older. If adopted, a booster could help reduce the overall burden of invasive meningococcal disease in countries with established infant MenB programmes.
